Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2623-2629
doi: 10.1161/01.CIR.0000037748.19282.7D
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freedman, J. E.
Right arrow Articles by Cannon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, J. E.
Right arrow Articles by Cannon, C.
Related Collections
Right arrow Other Ethics and Policy
Right arrow AHA Statements and Guidelines
Right arrow Acute coronary syndromes
Right arrow Acute myocardial infarction
Right arrow Acute Stroke Syndromes

(Circulation. 2002;106:2623.)
© 2002 American Heart Association, Inc.


AHA Scientific Statement

Medication Errors in Acute Cardiac Care

An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke

Jane E. Freedman, MD; Richard C. Becker, MD; Jesse E. Adams, MD; Steven Borzak, MD; Robert L. Jesse, MD; L. Kristin Newby, MD; Patrick O’Gara, MD; John C. Pezzullo, PhD; Richard Kerber, MD; Bernice Coleman, RN, PhD; Joseph Broderick, MD; Sally Yasuda, MS, PharmD; Christopher Cannon, MD


Key Words: AHA Scientific Statements • medical errors • medication errors • patients • drugs


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Medical errors occur commonly among hospitalized patients, with adverse events occurring in an estimated 3.7% to 16.6% of hospital admissions.1 Extrapolation of this information has led to an estimate of at least 44 000 deaths in US hospitals due to medical errors that are also commonly associated with complex or urgent care and prolonged hospital stays.2 In addition, preventable adverse medical events are more frequent among elderly patients, with an incidence of 5.3% compared with 2.8% in patients <65 years of age.3 This difference is attributed to the increased clinical complexity of care in the elderly, rather than to age bias, which highlights the contribution of multiple medication use to adverse outcome.2,3 Supporting the complexity hypothesis is a 1992 study of the prevalence and types of adverse events in Utah and Colorado, which showed that adverse drug events were the leading cause (19.3%) of all nonoperative adverse events.4

The importance of medical errors as a major contribution to adverse events has been the recent focus of several reviews and initiatives. Medication errors have recently been evaluated by the Institute for Safe Medical Practices (ISMP), and the British Medical Journal devoted a special issue to the subject of medical errors (March 18, 2000). The US Institute of Medicine (IOM) also published an extensive report examining the prevalence and reviewing potential causes of medical mistakes.5 The IOM’s report stated: "The problem is not bad people; the problem is that the system [of medical care] needs to be made safer."5

The definition of . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
JAMAHome page
K. P. Alexander, A. Y. Chen, M. T. Roe, L. K. Newby, C. M. Gibson, N. M. Allen-LaPointe, C. Pollack, W. B. Gibler, E. M. Ohman, E. D. Peterson, et al.
Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes
JAMA, December 28, 2005; 294(24): 3108 - 3116.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. H. Mehta, J. H. Alexander, F. Van de Werf, P. W. Armstrong, K. S. Pieper, J. Garg, R. M. Califf, and C. B. Granger
Relationship of Incorrect Dosing of Fibrinolytic Therapy and Clinical Outcomes
JAMA, April 13, 2005; 293(14): 1746 - 1750.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Cucchiara, S. Messe, and S. E. Kasner
Danger of Treatment Protocols
Stroke, May 1, 2003; 34 (5): e19 - e19.
[Full Text] [PDF]